Insider Transactions in Q2 2022 at Steris PLC (STE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
2,659
-8.69%
|
$545,095
$205.31 P/Share
|
|
Jun 02
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.19%
|
$83,536
$227.32 P/Share
|
|
Jun 02
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-1.43%
|
$19,976
$227.32 P/Share
|
|
Jun 02
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.64%
|
$28,375
$227.32 P/Share
|
|
Jun 02
2022
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+7.77%
|
$102,976
$32.36 P/Share
|
|
Jun 02
2022
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,140
+13.18%
|
-
|
|
Jun 02
2022
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+27.1%
|
-
|
|
Jun 02
2022
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,476
+18.96%
|
-
|
|
Jun 02
2022
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
564
+8.43%
|
-
|
|
Jun 02
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,256
+5.41%
|
-
|
|
Jun 02
2022
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
900
+12.76%
|
-
|
|
Jun 02
2022
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,028
+21.86%
|
-
|
|
Jun 02
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
3,384
+9.85%
|
-
|
|
Jun 02
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+15.62%
|
-
|
|
Jun 01
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-3.28%
|
$39,338
$221.46 P/Share
|
|
Jun 01
2022
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
235
-4.31%
|
$51,935
$221.46 P/Share
|
|
Jun 01
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-2.39%
|
$149,175
$221.46 P/Share
|
|
Jun 01
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.67%
|
$9,282
$221.46 P/Share
|
|
May 31
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
942
-14.78%
|
$214,776
$228.2 P/Share
|
|
May 31
2022
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-2.54%
|
$184,680
$228.2 P/Share
|
|
May 31
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,769
-8.93%
|
$631,332
$228.2 P/Share
|
|
May 31
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.14%
|
$16,416
$228.2 P/Share
|
|
May 31
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-3.34%
|
$292,980
$228.2 P/Share
|
|
May 31
2022
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-5.84%
|
$169,176
$228.2 P/Share
|
|
May 31
2022
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-2.64%
|
$34,428
$228.2 P/Share
|
|
Apr 20
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
8,000
-20.5%
|
$2,040,000
$255.48 P/Share
|
|
Apr 20
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+17.01%
|
$536,000
$67.98 P/Share
|
|
Apr 07
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
8,000
-17.23%
|
$2,000,000
$250.0 P/Share
|